Stocks · NYSE · Healthcare · United States
NVO — Novo Nordisk A/S
Novo Nordisk A/S (NVO) is a healthcare stock listed on NYSE (United States). At the close of September 29, 2026 it traded at 38.31 (-1.03% on the day), -15.5% over one month, -20.4% over three months, -27.5% over twelve months. The InvestMuse composite score is +11 on a −100 to +100 scale, a mixed read that ranks #526 of about 1,221 assets. The strongest of its nine dimensions are Sector edge (+84) and Fundamentals (+67); the weakest is Regime (hidden Markov model) (-95). Its volatility regime from the hidden Markov model is Hot. 24 news articles in the last 30 days carried an average tone of +0.09 (on −1 to +1).
The facts
| Last close | 38.31 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -1.03% / -15.5% / -20.4% / -27.5% |
| 52-week range | 34.33 – 60.94 |
| Composite score | +11 / 100 · mixed view · rank #526 |
| Volatility regime (HMM) | Hot |
| Resistance levels | 21.00 |
| Trailing P/E | 1.8 |
| Market cap | $212.7B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)-95
- Technical indicators+32
- Trend-30
- Support / resistance0
- Fundamentals+67
- Sector edge+84
- News sentiment+9
- Momentum-10
- Chart patterns and zones+20
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.